Dorzolamide And Timolol Solution
Product Images NDC 69315-305

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Dorzolamide And Timolol (NDC 69315-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A (2a8d3274 3df9 4a65 A72f 086a57466c04 01)

FDA Label Image

C (2a8d3274 3df9 4a65 A72f 086a57466c04 02)

FDA Label Image

B (2a8d3274 3df9 4a65 A72f 086a57466c04 03)

Not available.*

FDA Label Image

F (2a8d3274 3df9 4a65 A72f 086a57466c04 04)

FDA Label Image

A (2a8d3274 3df9 4a65 A72f 086a57466c04 05)

FDA Label Image

B (2a8d3274 3df9 4a65 A72f 086a57466c04 06)

This text provides a brief instruction to snap off the dust cover by turning it clockwise to break the seal.*

FDA Label Image

C (2a8d3274 3df9 4a65 A72f 086a57466c04 07)

FDA Label Image

D (2a8d3274 3df9 4a65 A72f 086a57466c04 08)

This is a set of instructions to unscrew a cap that is colored blue.*

FDA Label Image

Picto (2a8d3274 3df9 4a65 A72f 086a57466c04 09)

This text provides instructions on how to apply eye drops. It suggests tilting your head backward, pulling your lower eyelid down slightly to create a pocket, and dispensing the drops gently with pressure.*

FDA Label Image

G (2a8d3274 3df9 4a65 A72f 086a57466c04 10)

This text is a set of instructions for using a product that requires a cap to be replaced after each use. The cap is blue in color and must be screwed down tightly.*

FDA Label Image

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 11)

This is a prescription drug named Dorzolamide HCI and Timolol Maleate Ophthalmic Solution prescribed for treating glaucoma and ocular hypertension. It contains Hydroxyethylcellulose, Mannitol, Sodium Citrate, Sodium Hydroxide, and Water for injection. It should be stored between 20°- 25°C (68°- 77°F) and protected from light. Each ml contains 20 mg of Dorzolamide HCI and 5 mg of Timolol maleate. The dosage varies according to the instructions provided by the manufacturer. The product is sterile when manufactured and should be dispensed in the original unopened container to ensure it remains uncontaminated.*

FDA Label Image

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 12)

This is a product information sheet for dorzolamide HCI and timolol maleate ophthalmic solution, used for treating glaucoma. The solution is sterile when produced and should not be used if the original package has been opened. It contains active ingredients of Dorzolamide HCI and Timolol maleate, and the inactive ingredients include hydroxyethyl cellulose, mannitol, sodium citrate, and water. The usual dosage is not mentioned, and the accompanying package insert must be referred to for the same. The solution should be dispensed by first snapping off the dust cover and then unscrewing the blue colored cap. The solution must be protected from light and kept at a temperature between 20°C and 25°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.